相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications of CKD and Mortality in the Kidney Early Evaluation Program (KEEP)
Lesley A. Stevens et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Longitudinal Assessment of Estimated Glomerular Filtration Rate in Apparently Healthy Adults: A Post hoc Analysis from the JUPITER Study (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Donald G. Vidt et al.
CLINICAL THERAPEUTICS (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease Implications for Policy
Joseph Menzin et al.
PHARMACOECONOMICS (2011)
Risk Implications of the New CKD Epidemiology Collaboration (CKD-EPI) Equation Compared With the MDRD Study Equation for Estimated GFR: The Atherosclerosis Risk in Communities (ARIC) Study
Kunihiro Matsushita et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein A Secondary Analysis From the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) Trial
Paul M. Ridker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls
Stein Ivar Hallan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD
Michael J. Koren et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Definition and Classification of CKD: The Debate Should Be About Patient Prognosis-A Position Statement From KDOQI and KDIGO
Kai-Uwe Eckardt et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Bengt C. Fellstroem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease
James Shepherd et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion
Auke H. Brantsma et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Giovanni F. M. Strippoli et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Prevalence of chronic kidney disease in the United States
Josef Coresh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The treating to new targets (TNT) study
James Shepherd et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Chronic kidney disease and mortality risk: A systematic review
Marcello Tonelli et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease
M Tonelli et al.
CIRCULATION (2005)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
AS Levey et al.
KIDNEY INTERNATIONAL (2005)
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization
DS Keith et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of pravastatin on cardiovascular events in people with chronic kidney disease
M Tonelli et al.
CIRCULATION (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population
DH Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Chronic kidney disease and cardiovascular disease in the Medicare population
AJ Collins et al.
KIDNEY INTERNATIONAL (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency
M Tonelli et al.
ANNALS OF INTERNAL MEDICINE (2003)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
JFE Mann et al.
ANNALS OF INTERNAL MEDICINE (2001)
Cardiovascular disease and chronic renal disease: A new paradigm
MJ Sarnak et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
